Home » Topics » Regulatory » NMPA

NMPA
RSS

F-647 approved in China

Sep. 22, 2011

First iguratimod product approved in China

Aug. 26, 2011

High-dose EPIAO approved in China to treat chemotherapy-associated anemia

July 14, 2011

Chinese health authorities approve Novo Nordisk's Victoza for type 2 diabetes

March 16, 2011

Hutchison MediPharma begins phase I trial of fruquintinib in China

Feb. 2, 2011

TPIAO approved in China for idiopathic thrombocytopenic purpura

Jan. 26, 2011

Sinovac receives SFDA approval to begin trials of EV-71 vaccine

Dec. 29, 2010

Aoxing Pharma begins trial of sublingual buprenorphine/naloxone for opioid addiction

Dec. 13, 2010

MicuRx files IND for MRX-I antibiotic in China

March 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...